Target intelligence / Profile preview

Lipoamide-containing enzyme

Molecular classification
Enzyme, Oxidoreductase, Multi-enzyme complex component
01

Overview

Lipoamide-containing enzymes are a group of mitochondrial multi-enzyme complexes that utilize lipoic acid covalently attached to lysine residues as an essential prosthetic group. These include the pyruvate dehydrogenase complex, 2‑oxoglutarate dehydrogenase complex, branched-chain alpha-keto acid dehydrogenase complex, and the glycine cleavage system. Each contains one or more subunits that use lipoamide for catalyzing oxidative decarboxylation reactions central to energy metabolism—converting key metabolites into acetyl-CoA or succinyl-CoA while reducing NAD+ to NADH for ATP production. The best-characterized example is dihydrolipoamide dehydrogenase (DLD), which acts as the E3 component common across these complexes. Mutations affecting these enzymes can cause severe metabolic diseases due to impaired mitochondrial energy generation. Because “lipoamide-containing enzymes” refers collectively rather than individually, this entry is too broad for precise drug targeting without specifying which member is meant.

Other names
Lipoamide-dependent enzymeLipoic acid–containing enzymeMulti-enzyme complexes with lipoamide prosthetic group
02

Mechanism of action

Catalysis of redox reactions involving transfer of acyl groups and electrons between substrates and coenzymes such as NAD+ and FAD

03

Biological functions

Energy metabolismOxidative decarboxylation of alpha-keto acidsATP production via oxidative phosphorylationRedox balance in cells
04

Disease associations

Metabolic disorders (e.g., pyruvate dehydrogenase deficiency)Neurodegenerative disease (e.g., Friedreich's ataxia via DLD deficiency)Mitochondrial diseases
05

Safety considerations

Deficiency leads to lactic acidosis, neurological impairment, metabolic crises
06

Interacting drugs

None specific to the entire class; some cofactors and inhibitors may interact with individual members (e.g., dichloroacetate for pyruvate dehydrogenase kinase inhibition)
07

Biomarkers

Blood lactate/pyruvate ratio (for PDH activity)Acylcarnitine profile abnormalities in branched-chain ketoaciduria

Beyond the preview

Go deeper on Lipoamide-containing enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipoamide-containing enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call